Savior Lifetec - Asset Resilience Ratio

Latest as of December 2025: 18.86%

Savior Lifetec (4167) has an Asset Resilience Ratio of 18.86% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Savior Lifetec working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

NT$789.00 Million
≈ $24.86 Million USD Cash + Short-term Investments

Total Assets

NT$4.18 Billion
≈ $131.82 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Savior Lifetec's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Savior Lifetec (4167) total assets.

Liquid Assets Composition Over Time

This chart breaks down Savior Lifetec's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 4167 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$789.00 Million 18.86%
Total Liquid Assets NT$789.00 Million 18.86%

Asset Resilience Insights

  • Good Liquidity Position: Savior Lifetec maintains a healthy 18.86% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Savior Lifetec Industry Peers by Asset Resilience Ratio

Compare Savior Lifetec's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
CSL Ltd
AU:CSL
Biotechnology 0.41%
Vaxcyte Inc
NASDAQ:PCVX
Biotechnology 41.54%
Bachem Holding AG
SW:BANB
Biotechnology 0.00%
Definium Therapeutics, Inc.
NASDAQ:DFTX
Biotechnology 38.51%
Chongqing Zhifei Bio Products
SHE:300122
Biotechnology -0.08%
HLB Co. Ltd
KQ:028300
Biotechnology 3.29%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076
Biotechnology 2.30%
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229
Biotechnology 0.12%

Annual Asset Resilience Ratio for Savior Lifetec (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Savior Lifetec.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 18.86% NT$789.00 Million
≈ $24.86 Million
NT$4.18 Billion
≈ $131.82 Million
+1.47pp
2024-12-31 17.39% NT$761.06 Million
≈ $23.98 Million
NT$4.38 Billion
≈ $137.87 Million
+10.74pp
2023-12-31 6.65% NT$254.27 Million
≈ $8.01 Million
NT$3.82 Billion
≈ $120.44 Million
-6.14pp
2022-12-31 12.79% NT$563.76 Million
≈ $17.76 Million
NT$4.41 Billion
≈ $138.90 Million
+12.44pp
2021-12-31 0.35% NT$15.71 Million
≈ $495.01K
NT$4.54 Billion
≈ $142.99 Million
-2.13pp
2020-12-31 2.47% NT$119.65 Million
≈ $3.77 Million
NT$4.84 Billion
≈ $152.38 Million
+1.88pp
2019-12-31 0.60% NT$24.13 Million
≈ $760.13K
NT$4.03 Billion
≈ $127.07 Million
-1.60pp
2018-12-31 2.19% NT$77.42 Million
≈ $2.44 Million
NT$3.53 Billion
≈ $111.20 Million
+2.18pp
2017-12-31 0.01% NT$420.00K
≈ $13.23K
NT$3.95 Billion
≈ $124.37 Million
--
pp = percentage points

About Savior Lifetec

TWO:4167 Taiwan Biotechnology
Market Cap
$186.81 Million
NT$5.93 Billion TWD
Market Cap Rank
#16880 Global
#822 in Taiwan
Share Price
NT$19.10
Change (1 day)
+0.26%
52-Week Range
NT$16.70 - NT$21.85
All Time High
NT$40.63
About

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, mero… Read more